High Response to Cetuximab in a Patient With EGFR -Amplified Heavily Pretreated Metastatic Triple-Negative Breast Cancer - Archive ouverte HAL Access content directly
Journal Articles JCO precision oncology Year : 2019

High Response to Cetuximab in a Patient With EGFR -Amplified Heavily Pretreated Metastatic Triple-Negative Breast Cancer

(1) , , (1) , (1) , (1) , (1) , (1) , (2) , (3) , (1) , (3) , (1) , (1) , (1) , (1) , (1)
1
2
3
Marc Lopez
Not file

Dates and versions

hal-03623686 , version 1 (29-03-2022)

Identifiers

Cite

Renaud Sabatier, Marc Lopez, Arnaud Guille, Emilien Billon, Nadine Carbuccia, et al.. High Response to Cetuximab in a Patient With EGFR -Amplified Heavily Pretreated Metastatic Triple-Negative Breast Cancer. JCO precision oncology, 2019, 3, pp.1-8. ⟨10.1200/po.18.00310⟩. ⟨hal-03623686⟩

Collections

CNRS UNIV-AMU CRCM
4 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More